Epilepsy is a major societal burden with a significant impact on patients' health and quality of life. The primary goal in epilepsy management is to achieve freedom from all types of seizures. Early treatment with antiseizure medications plays a crucial role in this regard, preventing seizure recurrence, limiting disea...
D. García-Azorín, Luis Lobato, Javier Riancho et al.· Neurological Therapeutics· 0 citations
OBJECTIVE
Functional (dissociative) seizures (FDS) are increasingly recognized among individuals with epilepsy, intellectual disability (ID), and psychiatric disorders, but their occurrence in PCDH19-clustering epilepsy (CE) has not been systematically described. We aimed to characterize the clinical features, diagnost...
Rita Cagigal, J. Peña-Ceballos, Patrick B. Moloney et al.· Epileptic disorders· 0 citations
BACKGROUND
Loss-of-function variants in SRRM2, encoding the spliceosomal protein SRm300 involved in pre-messenger RNA splicing, have recently been associated with a neurodevelopmental disorder. Although seizures have been reported in some affected individuals, the electroclinical phenotype of SRRM2-related epilepsy has...
Daniel Fouz-Ruiz, Á. Beltrán-Corbellini, B. D. de Vries et al.· European journal of paediatr...· 0 citations
CNB was associated with sustained effectiveness and acceptable tolerability across pediatric DEEs and slow weight-based titration and proactive simplification of sodium channel blockers and clobazam may optimize benefit-risk.
Á. Aledo-Serrano, Adrián Valls-Carbó, E. González-Alguacil et al.· Epilepsia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
